Gene: PDE4B
Official Full Name: phosphodiesterase 4Bprovided by HGNC
Gene Summary: This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. The encoded protein regulates the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. Altered activity of this protein has been associated with schizophrenia and bipolar affective disorder. Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07532 | PDE4B Knockout cell line (HeLa) | Human | PDE4B | 1:3~1:6 | Negative | Online Inquiry |
KO07533 | PDE4B Knockout cell line (HCT 116) | Human | PDE4B | 1:2~1:4 | Negative | Online Inquiry |
KO07534 | PDE4B Knockout cell line (A549) | Human | PDE4B | 1:3~1:4 | Negative | Online Inquiry |
PDE4B Gene Knockout Cell Lines are genetically engineered cell lines in which the phosphodiesterase 4B gene (PDE4B) has been selectively disrupted, allowing researchers to study the functional consequences of PDE4B depletion in various biological contexts. PDE4B is an important enzyme involved in the hydrolysis of cyclic adenosine monophosphate (cAMP), a critical intracellular signaling molecule. Its regulation has significant implications in inflammatory responses, neurobiology, and cancer biology.
The key mechanism of these cell lines lies in their ability to modulate cAMP levels, providing an unprecedented tool for researchers to dissect the roles of PDE4B in cellular signaling pathways. By knocking out the PDE4B gene, these cell lines allow for the exploration of downstream signaling effects, providing insight into disease mechanisms and potential therapeutic strategies. This approach has critical applications in pharmacological research, particularly in developing novel anti-inflammatory drugs and in studying neurodegenerative diseases where PDE4B is a pivotal target.
Compared to other genetic models, PDE4B Gene Knockout Cell Lines offer unique advantages, particularly in their specificity and ease of use. Traditional methods such as small molecule inhibitors may lack specificity and can produce off-target effects, while these knockout models allow for direct observation of PDE4B function in vitro. Additionally, they serve as a robust platform for high-throughput screening, allowing researchers to test large libraries of compounds rapidly.
For researchers and clinicians, the availability of these cell lines represents a significant advancement in understanding the complex roles of PDE4B in health and disease. Their application can facilitate the discovery of groundbreaking treatments and enhance our understanding of cellular signaling in disease states.
With a commitment to innovation, our company specializes in providing high-quality biological products that empower scientific research. Our expertise in developing genetic models ensures that researchers have access to reliable tools that can accelerate their investigations and contribute to the advancement of biomedical knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.